Found 24 matching trials
Allo HSCT Using RIC and PTCy for Hematological Diseases
PHASE2This is a Phase II study following subjects proceeding with our Institution...
Location
Masonic Cancer Center at University of Minnesota
Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer
PHASE1This study will test how well a new combination of three drugs (Letrozole, ...
Location
University of Alabama at Birmingham
RAD001 Plus Carboplatin in Breast Cancer Patients
PHASE2This study investigates the effectiveness of combination of carboplatin and...
Location
NYU Clinical Cancer Center
Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long COVID-19
PHASE3The study is conducted in New York, New York at The Cohen Center for Recove...
Location
Icahn School of Medicine at Mount Sinai
Altering Memories That Increase Risk of Relapse in Alcohol Use Disorders
PHASE1The purpose of this study is to examine the effects of rapamycin (sirolimus...
Location
Medical University of South Carolina
Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia
PHASE4The goal of this clinical trial is to evaluate the efficacy and safety of s...
Location
Xiangya Hospital of Central South University
Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI
PHASE2Post-menopausal women with hormone-receptor positive (HR+) metastatic breas...
Location
Marin Cancer Care
Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
PHASE1The purpose of this study is to test the effectiveness of a drug called tem...
Location
Columbia University Irving Medical Center
A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma
PHASE2Determine the objective response rate in sarcoma patients treated with hydr...
Location
Shin Kong Wu Ho-Su Memorial Hospital
Comparison of Safety and Efficacy of de Novo Everolimus
NANowadays, de novo everolimus regimen in renal transplant patients is consid...